InSphero
Latest round
- Series A
Last raised
- Aug 2010
Total raised
- $1.7M
Investors
- 2
About InSphero
Founded in 2009 and headquartered in Zurich, Switzerland, InSphero AG focuses on creating innovative solutions for drug discovery.InSphero specializes in advanced 3D in vitro models that assist in non-animal drug testing. Their flagship product, the Akura™ Plates, enhances automation and efficiency in cell culture, allowing high-throughput analysis crucial for pharmaceutical and biotechnological applications.InSphero generates revenue through direct sales of its 3D in vitro models and associated services, primarily to pharmaceutical and biotech clients.
Who invested in InSphero
2 investors across 1 round
See all investors in InSphero
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 2, 2010
Amount
$1.7M
Investors
Questions about InSphero
Who invested in InSphero?
InSphero has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has InSphero raised?
InSphero has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did InSphero last raise money?
InSphero's most recent round on record is a Series A, in Aug 2010.
What does InSphero do?
Founded in 2009 and headquartered in Zurich, Switzerland, InSphero AG focuses on creating innovative solutions for drug discovery.
Where is InSphero headquartered?
InSphero is headquartered in Zurich, Switzerland.
Which VCs invest in companies like InSphero?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at InSphero's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like InSphero? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.